Navigation Links
CVS Caremark Appoints Dr. William Shrank as Chief Scientific Officer and Chief Medical Officer, Provider Innovation and Analytics
Date:11/12/2013

WOONSOCKET, R.I., Nov. 12, 2013 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced the appointment of William Shrank, MD to the position of Chief Scientific Officer and Chief Medical Officer, Provider Innovation and Analytics.  In this role, Dr. Shrank will focus on the development of innovative pharmacy solutions to help improve the quality of care while lowering costs in order to help health care providers deliver services to distinct patient populations.  Dr. Shrank will oversee the company's overall research and clinical program development with the goal of delivering new methods of evaluating innovative programs and initiatives.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Dr. Shrank has extensive experience in pharmaceutical outcomes research and has published extensively on topics including the evaluation of various pharmacy benefit designs, the Medicare Part D Prescription Drug benefit, medication adherence for chronic conditions and ensuring high-quality patient communications regarding the risks and benefits of prescribed medications.  Prior to joining CVS Caremark, Dr. Shrank was a practicing physician with Brigham Internal Medicine Associates as well as an Assistant Professor at Harvard Medical School. Previously Dr. Shrank served as Director, Research and Rapid-Cycle Evaluation for the Center for Medicare & Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS).

"As CVS Caremark continues to focus on identifying and developing innovative pharmacy care programs that improve outcomes and reduce overall costs, Will's depth of experience as a researcher make him uniquely qualified to oversee our research agenda," commented Troyen A. Brennan, MD, MPH, Executive Vice President and Chief Medical Officer of CVS Caremark.  "His insights and expertise will enable us to continue to develop new solutions to improve care and quality for patients dealing with chronic disease."

"I look forward to working with the team at CVS Caremark to find new ways to further the company's research efforts," said Dr. Shrank. "To date, CVS Caremark has built a strong reputation as a leader in medication adherence research and we look forward to expanding upon this focus and uncovering new learnings to help our clients improve outcomes while managing cost."

Dr. Shrank received his Medical Degree from Cornell University Medical College, his Masters of Science degree in Health Services from the University of California at Los Angeles and his Bachelor's Degree from Brown University.

About CVS Caremark
CVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,600 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 750 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans.  As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications.  Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

Media Contact:
Christine Cramer
CVS Caremark
(401) 770-3317 
christine.cramer@cvscaremark.com


'/>"/>
SOURCE CVS Caremark
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Reports Record Third Quarter Results
2. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
3. CVS Caremark Research Finds New, More Accurate Method for Classifying Patient Medication Adherence Behaviors
4. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
5. CVS Caremark Hosts Grand Opening of State-of-the-Art Mail Service Pharmacy and Customer Center
6. CVS Caremarks Accordant Health Services Launches New Member-Focused Web Site
7. CVS Caremark Reports Record Second Quarter Results
8. CVS Caremark Announces Agreement in Principle with the Securities and Exchange Commission
9. CVS Caremark Corporation To Hold Second Quarter 2013 Conference Call
10. CVS Caremark in Partnership with Ocean Conservancy Cleans Up Nearly 25,000 Pounds of Trash from Shorelines across the Country
11. CVS Caremark Corporation Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 9, 2016 On Tuesday, February ... met with its Arthritis Advisory Committee to ... Johnson & Johnson,s Remicade and most likely ... the U.S. The Biologics Prescribers Collaborative (BPC) ... Alliance for Patient Access, American Association of ...
(Date:2/10/2016)... LONDON , February 10, 2016 ... window and M 1 receptor selectivity   ... Heptares StaR® technology, which has entered clinical development ... patients with dementia and schizophrenia.   --> ... StaR® technology, which has entered clinical development as ...
(Date:2/9/2016)... BILLERICA, Mass. , Feb. 9, 2016  Insulet Corporation ... in tubeless insulin pump technology with its OmniPod ... David A. Lemoine has been appointed to Insulet,s ... comprised of nine directors, eight of whom are independent. ... over 40 years of audit and finance experience and a ...
Breaking Medicine Technology:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the ability of Medicare Advantage organizations to deliver medical services via telehealth, estimated ... “ATA has been advocating for such language for many years. Although there ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... ... February 10, 2016 , ... Sherly Sulaiman, certified clinical hypnotherapist ... therapeutic sessions to help Los Angeles-area actors cope with rejection, improve their auditions, ... known as “Mindfulness for Actors and Artists,” has been featured in Daily ...
(Date:2/10/2016)... ... 10, 2016 , ... Early this week, Team Iconic at J. Walter Thompson ... as the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé ... their product, through activities that focus on better farming, better lives and better cocoa. ...
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services ... of Eastern Michigan last Friday in order to aid in the Flint water crisis. ... include a facility located in Clio, only 15 miles away from Flint. , “We ...
Breaking Medicine News(10 mins):